Schedule of Company’s Stock Warrant Activity (Details) - Warrant [Member] |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
$ / shares
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Beginning balance, shares | shares | 55,600 |
| Weighted average exercise price, beginning balance | $ / shares | $ 15.2 |
| Granted | shares | |
| Weighted average exercise price, granted | $ / shares | |
| Cancelled/Expired | shares | |
| Weighted average exercise price, cancelled/expired | $ / shares | |
| Exercised/Issued | shares | |
| Weighted average exercise price, Exercised/issued | $ / shares | |
| Ending balance, shares | shares | 55,600 |
| Weighted average exercise price, ending balance | $ / shares | $ 15.2 |
| Exercisable shares | shares | 55,600 |
| Weighted average exercise price, exercisable | $ / shares | $ 15.2 |
| X | ||||||||||
- Definition Weighted average exercise price, cancelled/expired. No definition available.
|
| X | ||||||||||
- Definition Exercisable shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercised/issued. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, granted. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|